Carbamazepine carries two FDA boxed warnings, the most serious safety label a medication can receive. The first warns of potentially fatal skin reactions, and the second warns of life-threatening blood disorders including aplastic anemia and agranulocytosis. Beyond these, the drug can affect the heart, liver, sodium levels, and developing pregnancies. Here’s what each of these risks actually looks like and who faces the greatest danger.
Severe Skin Reactions
The most feared dermatologic reactions are Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN), conditions where the skin essentially blisters and peels away from the body. These are medical emergencies that can be fatal. In countries with predominantly white populations, they occur in roughly 1 to 6 out of every 10,000 new users. In some Asian populations, the risk is about 10 times higher.
That elevated risk traces back to a specific genetic variant called HLA-B*15:02, found almost exclusively in people with ancestry from broad areas of Asia, including Chinese, Southeast Asian, and South Asian populations. The FDA requires genetic screening for this variant before starting carbamazepine in anyone from these backgrounds. If you test positive, carbamazepine should not be prescribed unless there is no reasonable alternative.
Dangerous Drops in Blood Cell Counts
Carbamazepine can suppress the bone marrow’s ability to produce blood cells. The combined incidence of serious blood disorders, including dangerously low platelet counts, agranulocytosis (a near-complete loss of infection-fighting white blood cells), and aplastic anemia (where the marrow stops making enough of all blood cell types), ranges from 1% to 2% of patients. The risk of developing agranulocytosis or aplastic anemia specifically is 5 to 8 times greater than in the general population, though both conditions remain rare in absolute terms.
Mild dips in white blood cell counts are relatively common and usually not dangerous. In one study of 977 patients, about 2.1% developed low white cell counts. The vast majority of these cases never progress to something more serious. The distinction matters: routine blood monitoring will often flag minor changes that look alarming on paper but resolve on their own. Treatment is typically stopped only when white blood cell counts or platelet counts drop below specific thresholds, which your prescriber will be watching for through regular blood draws.
Heart Rhythm Problems
Carbamazepine works by blocking sodium channels in the brain to control seizures, but it also blocks sodium channels in the heart. This can slow electrical conduction through the heart muscle, leading to a range of cardiac problems: abnormally slow heart rate (bradycardia), heart block where electrical signals between the upper and lower chambers are delayed or interrupted, widening of the QRS complex on an EKG, and in rare cases, cardiac arrest.
One study found that carbamazepine use was associated with a 1.9 times greater risk of sudden cardiac arrest compared to nonuse. Case reports of serious heart rhythm disturbances cluster heavily in older adults, with most reported cases involving patients over 55. If you already have a heart condition or conduction abnormality, this risk is especially relevant to discuss before starting the medication.
DRESS Syndrome
Drug Reaction with Eosinophilia and Systemic Symptoms, known as DRESS, is a multi-organ hypersensitivity reaction that typically appears 3 to 12 weeks after starting carbamazepine. It begins with fever and rash, then progresses to involve internal organs, most commonly the liver, kidneys, or lungs. Blood tests show a spike in a type of white blood cell called eosinophils, which signals an overactive immune response. DRESS can be life-threatening if not caught early, and it requires immediate discontinuation of the drug.
The delayed onset makes DRESS tricky to recognize. By the time symptoms appear, you may have been taking the medication for over a month without any problems. A new fever combined with a spreading rash during those first few months on carbamazepine should prompt urgent medical evaluation.
Liver Damage
Carbamazepine is processed by the liver, and it actually revs up the liver’s enzyme-producing machinery. This means that certain liver function tests will often come back mildly elevated, not because of damage, but because the liver is simply working harder to metabolize the drug. These routine elevations, particularly in enzymes like gamma-glutamyl transferase and alkaline phosphatase, are not a reason to stop treatment.
True liver injury is a different situation. Aggravated liver dysfunction or acute liver disease requires immediate withdrawal of the drug. Baseline liver function tests are standard before starting carbamazepine, with periodic retesting afterward, especially for people with a history of liver problems and for older adults.
Low Sodium Levels
Carbamazepine can cause the body to retain too much water relative to sodium, diluting sodium levels in the blood. This condition, called hyponatremia, tends to be dose-dependent, meaning higher doses carry greater risk. In a large study tracking epilepsy patients over 14 years, about 2.6% developed moderate to severe hyponatremia.
Mild cases may cause no noticeable symptoms. As sodium drops further, you might experience headaches, nausea, confusion, fatigue, or muscle cramps. Severe hyponatremia can cause seizures, which is particularly problematic when the medication is being taken to prevent seizures in the first place. Regular blood tests that include sodium levels help catch this before it becomes dangerous.
Risks During Pregnancy
Carbamazepine roughly doubles the risk of major birth defects when taken during pregnancy. A controlled study of 210 pregnancies found a major congenital anomaly rate of 7.5% with carbamazepine exposure, compared to about 3.2% in the general population. Neural tube defects, where the spinal cord or brain doesn’t form properly, have been specifically linked to carbamazepine in multiple studies, though not all research has confirmed this association. If you’re of childbearing age and taking carbamazepine, the risk to a future pregnancy is something to weigh carefully with your prescriber, ideally before conception rather than after.
What Monitoring Looks Like
Because of these risks, carbamazepine requires more lab work than many medications. Before your first dose, you should have a complete blood count, liver function tests, kidney function tests, and a sodium level drawn. If you have Asian ancestry, genetic testing for HLA-B*15:02 should happen before prescribing. Once you’re on the medication, blood counts and metabolic panels are repeated periodically, with closer monitoring during the first few months when reactions like DRESS and blood dyscrasias are most likely to emerge.
The early weeks are the highest-risk window for the most dangerous reactions. Skin changes, unexplained fevers, unusual bruising or bleeding, persistent sore throats, and mouth ulcers are all signals that something may be going wrong and warrant prompt evaluation.